Summary
Latest filing:
Chee Kong Choo is Director, 10% Owner of CytoMed Therapeutics Ltd (GDTC). 3 SEC Form 4 filings on record, most recently on 25 July 2026. Most recent open-market trade: bought $150K of GDTC on 25 July 2026. Lifetime open-market purchases: $729K.
Recent Transactions
5Every recent SEC Form 4 transaction Chee Kong Choo has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Chee Kong Choo's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Brian Taylor Slingsby - $43.35M of MLYS open-market activity in the last 12 months
- Framework Ventures IV L.P. - $42.62M of SDEV open-market activity in the last 12 months
- Eric M. Dube - $41.35M of TVTX open-market activity in the last 12 months
- Jesse J. Geiger - $41.11M of MEDP open-market activity in the last 12 months
- Mark Hancock - $40.97M of PACS open-market activity in the last 12 months
- EcoR1 Capital, LLC - $40.00M of AKTS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Chee Kong Choo?
Chee Kong Choo is a corporate insider, tracked as Director, 10% Owner of CytoMed Therapeutics Ltd (GDTC). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Chee Kong Choo submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Chee Kong Choo been buying or selling stock?
Recorded transactions: 5 open-market purchases ($729K) and 0 open-market sales across all tracked filings.
Where can I see all of Chee Kong Choo's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Chee Kong Choo and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
